Insecticides (India) revenue climbs 7% as profit dips slightly
Full-year revenue hit ₹2,140 crore, but net profit slipped to ₹139.41 crore. The board also confirmed a generational leadership transition.
— 3 earlier stories on Insecticides (India) Ltd. →What's new
- FY26 revenue rose 7% to ₹2,140.01 cr, while net profit fell to ₹139.41 cr.
- Sanskar Aggarwal replaces Nikunj Aggarwal as Whole Time Director.
- The board approved an ESPS for 200,000 shares, a 0.69% equity dilution.
Why this matters
Revenue growth failed to translate into higher earnings, suggesting margin pressure in the agrochemical business. The leadership change is a clear generational handoff, but the financial results show the company is still working to scale its bottom line.
What we're watching
- Whether the new ESPS improves retention or impacts future earnings per share.
- Operational margins in the upcoming quarters to see if profit growth recovers.
- The strategic direction under the new Whole Time Director.
The full read
Insecticides (India) closed FY26 with ₹2,140.01 crore in consolidated revenue, a 7% gain over the prior year. Growth stalled at the bottom line. Net profit slipped to ₹139.41 crore from ₹142.02 crore as margin pressures likely offset the gains in sales volume.
Alongside the results, the board formalized a generational transition in the promoter group: Sanskar Aggarwal will succeed Nikunj Aggarwal as Whole Time Director for a five-year term. The company also introduced an employee stock purchase scheme for 200,000 shares, which will dilute equity by roughly 0.69%. The results indicate a period where revenue expansion has not yet yielded bottom-line growth, and the leadership change is the most significant governance move, signaling a clear shift in management responsibility for the coming years.
Questions answered
- How did the company perform financially in FY26?
- Revenue grew by 7% to reach ₹2,140.01 crore. However, net profit declined to ₹139.41 crore, down from the ₹142.02 crore reported in the previous fiscal year.
- What changes occurred in the company's leadership?
- Mrs. Nikunj Aggarwal resigned as Whole Time Director. Her son, Mr. Sanskar Aggarwal, has been appointed to the role for a five-year term.
- What is the impact of the new employee stock purchase scheme?
- The board approved an ESPS for up to 200,000 equity shares. This represents a minor dilution of approximately 0.69% of the company's total equity capital.
- Is this a routine filing?
- Yes, it covers standard audited financial results for the fiscal year ended March 31, 2026, alongside board-approved governance and incentive changes.
Story so far
All notes on INSECTICID →- 28 May 2026 · 6:14 PM IST Insecticides (India) revenue climbs 7% as profit dips slightly
- today Insecticides (India) reports 19% revenue growth for Q4
- today Insecticides (India) targets 70% premium product mix by FY30
- today Insecticides (India) profit dips as promoter family reshuffles board